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ABSTACT 
 
Alcohol intake and the risk of various types of cancers have been previously correlated. 
Correlation though does not always mean that a causal relationship between the two is 
present. Excessive alcohol consumption is also correlated with other lifestyle factors and 
behaviours, such as smoking and increased adiposity, that also affect the risk of cancer and 
make the identification and estimation of the causal effect of alcohol on cancer difficult. 
Here, using individual level data for 322,193 individuals from the UK Biobank, we report the 
observational and causal effects of alcohol consumption on types of cancer previously 
suggested as correlated to alcohol. Alcohol was observationally associated with cancers of 
the lower digestive system, head and neck and breast cancer. No associations were 
observed when we considered those keeping alcohol consumption below the recommended 
threshold of 14 units/week. When Mendelian randomisation was used to assess the causal 
effect of alcohol on cancer, we found that increasing alcohol consumption, especially above 
the recommended level, was causal to head and neck cancers but not breast cancer. Our 
results where replicated using a two sample MR method and data from the much larger 
COGS genome wide analysis of breast cancer. We conclude that alcohol is causally related to 
head and neck cancers, especially cancer of larynx, but the observed association with breast 
cancer are likely due to confounding. The suggested threshold of 14 units/week appears 
suitable to manage the risk of cancer due to alcohol. 
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INTRODUCTION 
 
Harmful effects of excessive alcohol consumption have been suggested for various diseases, 
including liver cirrhosis, cancer and cardiovascular disease, as well as risk of injuries through 
accidents 123. In the case of the association of alcohol with cancer, both ethanol and the 
products of its metabolism from the cells are considered to be carcinogenic 4. A large body 
of work exists on the association between alcohol consumption and different types of 
cancer in model organisms and population samples 5–7. Recently, a meta-analysis of the 
cancer and alcohol observational literature produced a list of seven cancers, including 
cancers of the: oropharynx, larynx, oesophagus, liver, colon, rectum and female breast, that 
are associated with heavy alcohol consumption 8. These results have been widely publicized 
and currently form part of the official advice provided by the UK Chief Medical Officers’ Low 
Risk Drinking Guidelines. According to this consumption of alcohol should not exceed 14 
units per week for both men and women 9.  
 
There are multiple limitations of relying on observational associations to establish the causal 
role of alcohol on cancer and estimate its true effect on risk, especially when we are 
interested in either high or low levels of consumption. Alcohol consumption is associated 
with other cancer risk factors such as poorer diet high in fats and processed meat, obesity, 
and most importantly, smoking 10,11. Furthermore, measurement of alcohol consumption, in 
the vast majority of cases, relies on self-reported drinking habits. This requires the 
participants to recall how much they drink per day, week, or month period. Studies looking 
at the accuracy of self-reported alcohol consumption have found that under-reporting is 
common 12 and the inaccuracy of the provided information increases with increasing levels 
of consumption 13. Also, the longer the period required to recall, the less accurate the 
information provided is, with periods longer than a week considered unreliable 14. Although 
these limitations can be addressed through the use of randomised control trials, this is not 
an option in this case due to logistical and ethical problems. In such cases we can make use 
of the existing genetic variability as a natural randomised control study 15. Instead of 
randomly assigning individuals in cases and controls groups, we rely on genetic variation 
that affects alcohol consumption to identify those that are likely to consume more alcohol 
and those that are likely to consume less. As long as the chosen genetic variant is not 
associated with any of the possible confounders of the association between alcohol and 
cancer, we can use this variant as an unconfounded proxy of alcohol consumption to test 
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and estimate the effect of the associated level of alcohol consumption on risk of cancer. This 
methodology is described as Mendelian Randomisation (MR) and has been previously used 
to estimate the causal effect of low to moderate alcohol consumption on cardiovascular risk 
using a genetic variant from the alcohol dehydrogenase 1B gene (ADH1B) 3. The ADH1B 
gene codes for the ADH1B enzyme metabolising alcohol into acetaldehyde. A single 
nucleotide polymorphism (SNP) found in the ADH1B gene, located at rs1229984, changes 
arginine to histidine in the encoded protein which results in increased levels of 
acetaldehyde after alcohol consumption and elicits a negative reaction to alcohol16.  
 
Here using individual level data for 322,193 people from the UK Biobank study, we aimed to 
establish and estimate the causal effect of alcohol consumption on the risk of cancer types 
previously suggested as associated with alcohol consumption. 
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The UK Biobank is a large population study including information and biological samples for 
approximately 500,000 individuals. These were recruited between 2006 and 2011. The 22 
UK Biobank assessment centres throughout England, Wales and Scotland, collected baseline 
data from the participants in the form of questionnaires, physical and cognitive tests and 
blood and urine samples 17. The age range of the participants at the time of enrolment in 




Alcohol intake for each participant was measured through multiple questionnaires. 
Excessive drinking and drinking behaviour related problems were assessed through the 
mental health questionnaire. Consumption of alcoholic drinks in the past 24 hours was 
assessed through the diet questionnaire. We used average weekly intake data from the 
lifestyle and environment questionnaire, including information for both weekly and monthly 
consumption. These were split per alcoholic beverage. An example for the average weekly 
red wine intake question was: "In an average WEEK, how many glasses of RED wine would 
you drink? (There are six glasses in an average bottle)" 18. The mean answer to this question 
from 348,369 participants was 3.9 glasses per week. The total number of units consumed 
per week by each participants was calculated using information available from the NHS (see 
19 and https://www.lanarkshirelinks.org.uk/wp-content/uploads/2015/12/HWL-ALCOHOL-
KNOW-YOUR-LIMITS-SHEET.pdf). Participants who had indicated that they had reduced 
their alcohol consumption either due to their doctor’s advice or due to illness (UKB Field 
2664) were excluded. 
 
Cancer information 
Cancer diagnoses information for the UK Biobank participants was obtained through self-
reported questionnaires and through linkage to existing cancer registries, the Medical 
Research Information Service for England and Wales and the Information Service Division 
for Scotland. The cancer registries include information from the early 1970’s acquired 
through a variety of sources, including hospitals and cancer treatment centres. More 
information can be found at 
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http://biobank.ndph.ox.ac.uk/showcase/docs/CancerLinkage.pdf. The data are coded using 
the 10th revision of the International Classification of Diseases (ICD). All participants who 
had been diagnosed with a given cancer at any point were considered cases and those that 
had not been diagnosed with that cancer were considered controls. For this study, cancer 
outcomes for lip, oral cavity and pharynx (ICD 10: C00-C14), digestive organs (ICD10: C15-
26), larynx (ICD 10: C32) and for female only cases of breast cancer (ICD 10: C50) were used. 
We also made larger categories of these by grouping C00-C14 with C32 as head and neck 
cancers, C15-C26 as gastro-intestinal cancers, C15-C16 and C22-C25 as upper digestive 
cancers, C17-C21 as lower digestive cancers, and all codes used in a category of any cancer. 
In terms of individual cancer types, we analysed only those that had at least 100 cases 
recorded in the study. In addition, acute myocardial infarction (MI) (ICD 10: I21) was used as 
a positive control with a known causal association from previous analysis. 
 
Genotyping 
The rs1229984 variant was genotyped in 488,363 individuals as part of the two similar 
genome wide genotyping Affymetrix Axiom arrays used in the UK Biobank. Sample quality 
control metrics were provided by UK Biobank and were generated as described previously 
20. Samples were excluded from the analysis if they were determined to be outliers for 
missingness or heterozygosity, and if they had any sex chromosome aneuploidies or 
differences between reported and genetically inferred sex. Samples which did not have a 
White British ancestry were also excluded from this analysis. A list of related individuals was 
provided by UK Biobank and one individual from each related pair was excluded at random. 




We used R 3.5.1 for analysing and plotting the results21, unless otherwise stated. For the 
observational part of the study, we regressed the amount of alcohol consumed per week 
against each of the outcomes considered using a robust logistic regression from the 
“robust” R package 22 adjusting for age and sex. The analysis was replicated per category of 
alcohol consumption grouped as below the recommended threshold (1-14 units or alcohol 
per week), or above the recommended threshold (<14 units or alcohol per week). We tested 
the association of the rs1229984 on alcohol consumption using a robust linear regression 
model including an additive and a dominance deviation component. Due to evidence of 
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dominance, we repeated the analysis using a dominant minor allele coding for rs1229984 in 
all participants and in groups of alcohol consumption adjusting for age, sex, the first 4 
principal components (PCs) for the genetic variability of the genome, and the genotyping 
array used. We tested the association of the genotype with each of the outcomes through a 
logistic regression adjusted for age, sex, the 4 PCs, and genotyping array used. The analysis 
was replicated per category of alcohol consumption including for those reporting 0 units of 
alcohol consumed per week. To assess the causal role of alcohol consumption on cancer 
risk, we used the ivprobit command in Stata 15 23 with the robust option and the maximum 
likelihood estimator method, while adjusting for age, sex, PCs, and genotyping array used. 
The analysis was replicated for all other categories of alcohol consumption. To confirm our 
results we also used an external genome wide association (GWAS) of alcohol consumption 
that identified multiple genetic polymorphisms 24 that were used in a two sample MR 
through MR Base 25 with UK Biobank cancer data. For breast cancer, we also used an 
external outcome file from the publicly available COGS results 26. We accepted associations 
with a p-value < 0.05/15 = 0.003571 to adjust for the 15 different outcome measures tested. 
We also describe results with 95% confidence intervals (CIs) away from 0 or 1 accordingly 
but as probable associations. 
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RESULTS 
 
After filtering for poor genotyping and non-white British ethnic background and excluding 
those reporting changes in their drinking behaviour due to their doctor’s advice or due to 
illness, 322,193 individuals remained in the sample. The mean age of the sample was 56.8 
years (Standard Deviation (SD) 8 years), with participants on average slightly overweight 
with a BMI of 27.4 kg/m2 (SD 4.7 kg/m2). The sample included 54% females, and 60% 
reported current or previous smoking. The average units consumed were 13 units/week 
(interquartile range 19 units/week). More than a quarter of the sample (28%) reported no 
alcohol intake per week, 38% were consuming alcohol below the recommended threshold 
of intake (1-14 units/week), and 34% above this (>14 units/week). The frequency of the 
minor T allele of the ADH1B rs1229984 SNP was 2.2%. There was no evidence of association 
between the variant and any of the common risk factors for cancer (ever smoked p-value = 
0.197). Those carrying the minor rs1229984 allele were less likely to exceed the 
recommended level (p-value = 7.92×10-132) and more likely to report no average weekly 
alcohol consumption (p-value = 4.44×10-104). A summary of the overall sample separated per 
genotype is provided in Table 1. 
 
Observational associations between alcohol and cancer revealed that increasing alcohol 
consumption was associated with an increasing risk of cancer, including those of the lower, 
but not upper, digestive system and head and neck cancers. In terms of specific locations, 
alcohol was associated with neoplasms of the tonsils, larynx, colon and rectum, as well as 
breast cancer. Alcohol appeared protective for acute MI, used as a control outcome with a 
known association. Odds ratios, 95% confidence intervals and p-values can be seen in Table 
2. When the association between alcohol and cancer was tested in those drinking but within 
recommended intake limits, no evidence of association between level of alcohol 
consumption and cancer or acute MI was observed. In those exceeding the recommended 
level of alcohol, increasing intake was associated with cancers of the tongue, tonsils, larynx, 
oesophagus, colon, rectum, liver, and pancreas, as well as all broader categories tested (S 
Table 1). A probable association was present for stomach cancer but did not satisfy our 
multiple testing adjusted p-value threshold (S Table 1). No evidence of alcohol association 
with either acute MI or breast cancer were observed per category. No outcome had 
opposite direction of association per alcohol category. These results are graphically 
summarised in SFigure1. 
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The rs1229984 ADH1B variant showed evidence of dominance of the minor allele (p = 
0.0236). Using a dominant model, the variant was strongly associated with alcohol intake (F-
statistic 692.2, p-value 5.62×10-106) in the sample. Carriers of the minor T allele were 
consuming on average 2.1 units/week less that the homozygotes of the common allele. The 
association of the genetic variant with alcohol was also evident for both of those drinking 
below (F-statistic = 47.4, p-value = 2.63×10-13) and above (F-statistic = 69.9, p-value = 
1.20×10-6) the maximum recommended 14 units/week, with a difference of 0.35 and 0.87 
units/week less respectively. A genetic variant, or allele score, with an F-statistic > 10 for its 
association with the exposure is considered a strong instrument for use in MR. Testing the 
association between the variant and the cancer outcomes though, showed no evidence of 
association between the rs1229984 ADH1B variant and any of the cancer outcomes tested 
in the full sample, those reporting alcohol consumption of 1 to 14 units/week, or those 
drinking more than 14 units/week (STable 2). For those reporting no alcohol consumption 
per week, a probable association suggesting an increase of risk of rectal cancer with the 
minor allele was observed, but this is well within our expected false positives range (STable 
2). In those exceeding the recommended limit of alcohol consumption, we identified a 
protective effect of the minor allele of the genetic variant reducing alcohol use and acute MI 
(Odds ratio 0.61, CIs 0.44-0.85, p-value = 2.95×10-3) (STable 2).  
 
The instrumental variable regression estimating the causal effect of alcohol consumption on 
the risk of cancer in all individuals showed no evidence of a causal effect at our multiple 
testing adjusted p-value threshold, though a probable association was seen with the risk of 
larynx cancer (probit coefficient 0.044; CIs 0.004-0.085) (Table 2). No evidence of a causal 
association between alcohol consumption and cancer risk for those reporting that they 
drink but on average less than 14 units/week was observed. Those exceeding the suggested 
limit however showed evidence of causal association between alcohol and head and neck 
cancer (0.053; CIs 0.033-0.073). Probable associations were also seen with an increase of 
the risk of larynx cancer (0.049; CIs 0.001-0.097), and a decrease of the risk of tongue cancer 
(-0.47; CIs -0.082 - -0.012) with alcohol, though their respective p-values do not reach our 
multiple testing adjusted threshold (STable 3). For risk of MI we identified evidence of 
association with alcohol consumption in those drinking more than the recommended 
maximum (0.048 CIs 0.033-0.062) but not for those drinking below it or in the sample 
overall (STable 3). The results are visually summarised in Figure 1. 
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The two sample MR using the recently published polygenic associations with alcohol 
consumption 24 did not fundamentally change our results (Table 2). The biggest difference 
was the probable causal association of any cancer category with alcohol consumption (OR 
1.45, CIs 1.12-1.89), though MR Egger results did not support this effect. Alcohol had a 
probable causal association to head and neck cancer for both the inverse variance weighted 
(OR 3.86, CIs 1.33-11.21) and MR Egger method. Similarly, cancer of the larynx had again 
evidence of a probable causal association not reaching our multiple testing adjusted p-value 
(OR 15.22, CIs 1.65-140.12). Cancer of the oesophagus also showed probable evidence of a 
causal association (ORs 4.18, CIs 1.02-17.18). Alcohol consumption was not associated with 
the risk of breast cancer in either of the analyses we performed using events in UK Biobank 
or when we used outcome associations from the largest breast cancer GWAS available from 
COGS 26 (OR 0.96, CIs 0.77-1.18) (Table 2 & SFigure 2). 
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DISCUSSION 
 
We set out to identify and estimate the causal effect of self-reported weekly alcohol 
consumption on the risk of cancer in the parts of the body in direct contact with alcohol 
during digestion. We also included breast cancer as a common cancer correlated to alcohol 
consumption and acute MI as a control outcome for which the causal effect of alcohol was 
previously well established 3,27. We found observational associations between weekly 
alcohol consumption and cancers of the digestive system. The genetic variant chosen as an 
instrument for alcohol consumption was strongly associated with the exposure but not with 
the cancer outcomes. In those exceeding the recommended maximum of 14 units/week, 
alcohol was causally associated with the risk of head and neck cancer. Only limited evidence 
was available for the causal effect of alcohol to specific cancers and these were focused on 
cancer of the larynx.  
 
In terms of the observational associations between alcohol consumption and risk of cancer, 
our result correspond well to what has been previously reported in a meta-analysis of 572 
studies 8. We confirmed the association of alcohol consumption with an increasing 
occurrence of cancers in the area of the pharynx (specifically tonsils), as well as colorectal, 
larynx and breast cancer. We did not replicate the association with oesophageal or liver 
cancers, except for those consuming more than the recommended maximum of 14 
units/week, which also showed an increasing number of cancers of the oral cavity and 
pharynx, colorectal, pancreas and larynx. Small intestine was not affected by alcohol in any 
of the categories tested, in both our work and the published meta-analysis. For individuals 
drinking less than the recommended threshold we did not identify any associations of 
alcohol consumption with cancer which is in accordance with the published data, except for 
oral cavity and pharynx 8,28. A J or U shaped correlation has been suggested between alcohol 
and risk of cardiovascular disease 29,30. Here using acute MI we found a protective effect of 
alcohol in the overall sample that attenuated in magnitude with increasing category of 
alcohol consumption in accordance with the idea of a non-linear relationship. 
 
The rs1229984 variant we selected as the genetic instrument, based on other published MR 
work 3,27,25, was strongly associated with weekly alcohol consumption in our sample. The 
variant also had other characteristics of a good instrument, such as no evidence of an 
association of the genetic variant with any of the probable confounders or with any of the 
All rights reserved. No reuse allowed without permission. 
not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprint (which wasthis version posted July 26, 2019. ; https://doi.org/10.1101/19002832doi: medRxiv preprint 
cancer types tested in those reporting no alcohol consumption per week. Though, the latter 
should be considered with caution, since an individual’s report of no weekly alcohol 
consumption does not rule out the occasional drink. We did not find any associations 
between the variant and the cancer types tested in the overall sample. The lack of 
association of the specific variant with stomach cancer agrees with other published data 
223132, though other alcohol associated SNPs have been reported as associated with the 
outcome. The rs1229984 variant though has been previously associated with aerodigestive 
cancers, including oral and pharynx, larynx and oesophagus cancers 333435. Despite not 
identifying the reported associations, our estimated effects per unit/week were very close 
to what was reported earlier in a sample of 3,800 cases and 5,200 controls 33, suggesting 
that more cancer cases were required to identify some of the associations present. There is 
some uncertainty for the association of the specific variants with colorectal cancers with 
some studies reporting an association 36 and others reporting no effect 37. We did not find 
an association of the variant with any of the lower digestive system cancers. Although the 
association of the variant used has been previously shown 3 and confirmed in a different 
population 27 we were only able to replicate the result in those reporting an alcohol intake 
higher than the recommended threshold. 
 
Although our variant associations failed to identify causal effects reported in the literature, 
the instrumental variable regression strongly suggested that alcohol consumption higher 
than 14 units/week was causal to the risk of head and neck cancer and MI. The effect on 
head and neck cancer appeared to be, at least, partially attributed to an increase risk of 
cancer of the larynx. These results correspond well to the published associations of the 
genetic variant, described earlier 333435, as well as studies showing that laryngeal cancers are 
reversible following alcohol cessation 38. The observed non-significant increase in the risk of 
cancer for those consuming alcohol in light and moderate quantities below the 
recommended threshold has been previously reported 28 though conflicting observational 
results are also available, especially for breast cancer. We did not identify any evidence of 
causal association between alcohol consumption and breast cancer, either for the 3,170 UK 
Biobank or the 122,977 COGS recorded events, irrespective of genetic instrument used. This 
suggests that the relationship between alcohol and breast cancer 39 is at least severely 
confounded. Smoking, poor diet and obesity are possible confounders that can also affect 
the suggested mechanisms for the link between alcohol and breast cancer 40.  
 
All rights reserved. No reuse allowed without permission. 
not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprint (which wasthis version posted July 26, 2019. ; https://doi.org/10.1101/19002832doi: medRxiv preprint 
Limitations exist in our study and they can explain some of the inconsistences we see with 
published results. The main issue with our data is the lack of statistical power due the 
relatively small number of recorded events. Although the study population is very large, 
reaching the 500,000 individuals, it includes people that are more affluent, better educated 
and in better health than the underlying population of the UK at this age range 41. This is 
evident for both the number of cancer events, which are 10-20% lower than expected, and 
alcohol consumption, with UK Biobank participants less likely to be alcohol abstainers but 
also less likely to drink alcohol every day compared to the general population 41. For liver 
cancer, where alcohol is a well-known major factor for primary hepatocellular cancers 42, 
our results should be interpreted as not covering the directly alcohol associated carcinomas. 
This is due to our removal from the data of those that changed their alcohol consumption 
following their doctor’s advice or illness, likely to include these with alcohol related liver 
disease, and due to that the vast majority of liver cancer cases attributed to cancer cells 
traveling to the liver from other parts of the body, instead of being primary liver tumours. 
 
To summarise, we showed that alcohol consumption causes cancer of the head and neck 
and acute myocardial infarction in those exceeding the recommend threshold of 14 
units/week. No causal effect of alcohol on cancer was found in those drinking below the 
threshold. No causal effect of alcohol was observed between alcohol consumption and 
breast cancer in women, in either the individual level data available here or previously 
published summary data, suggesting that the observational associations are more likely 
confounded. Our results contribute to the accumulating evidence for the danger posed from 
excessive alcohol use for some types of cancer, but not others, and the introduction of the 
lower 14 units/week threshold as a safe level of alcohol consumption in terms of cancer risk 
management. 
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Table 1      







% below recommended 
threshold (1-14 
units/wk) 
% above recommended 
threshold (>14 
units/wk) 
ALL 322193 54.0 56.8 ±8.0 27.3 ±4.7 59.7 13.0 (19) 0.28 0.38 0.34 
CC 307752 54.1 56.8 ±8.0 27.3 ±4.7 59.6 13.2 (19) 0.28 0.38 0.35 
CT 14263 52.7 57.1 ±8.0 27.1 ±4.6 60.2 9.7 (14) 0.36 0.39 0.25 
TT 178 53.4 57.5 ±7.5 26.9 ±3.9 59.0 8.9 (15) 0.45 0.29 0.26 
          
 
Table 1: Characteristics of the sample used in the analysis. Summary for the entire sample and per genotype of the rs1229984 SNP is provided. There is no 
evidence that the rs1229984 SNP is associated with the selected classical risk factors for cancer. The distribution of alcohol consumption is not normally 
distributed and the standard deviations should be interpreted with caution. 
  
All rights reserved. No reuse allowed without permission. 
not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprint (which wasthis version posted July 26, 2019. ; https://doi.org/10.1101/19002832doi: medRxiv preprint 
 
 
Table 2: Results of observational, one and two sample MR analysis for the relationship between alcohol consumption in units/week and risk of cancer in all 
participants. U = upper; L = lower; CI = confidence interval; probability = ivprobit coefficient; MI = myocardial infarction. 
 
 
(An Excel version is available in the Supplementary Materials.)
Table 2
cancer N OR U 95% CI L 95% CI p probability U 95% CI L 95% CI p OR U 95% CI L 95% CI p p (MR-Egger)
C02 Tongue 137 0.997 1.008 0.986 6.01E-01 -0.025 0.022 -0.072 3.04E-01 0.524 5.870 0.047 6.00E-01 7.18E-01
C09 Tonsil 157 1.013 1.019 1.007 9.54E-06 0.041 0.084 -0.003 6.73E-02 8.443 83.466 0.854 6.80E-02 1.45E-01
C15 Oesophagus 490 0.997 1.003 0.991 3.39E-01 0.020 0.058 -0.017 2.89E-01 4.177 17.181 1.016 4.75E-02 7.67E-01
C16 Stomach 340 0.992 1.000 0.984 4.01E-02 0.032 0.069 -0.005 8.60E-02 4.289 20.905 0.880 7.16E-02 4.08E-01
C17 Small intestine 148 0.994 1.006 0.983 3.56E-01 -0.015 0.040 -0.070 5.90E-01 0.419 4.104 0.043 4.55E-01 4.53E-01
C18 Colon 2446 1.004 1.007 1.002 4.26E-04 0.009 0.030 -0.012 3.86E-01 1.274 2.371 0.685 4.44E-01 6.14E-01
C19 Rectosigmoid junction 306 1.005 1.011 0.999 8.96E-02 0.007 0.055 -0.042 7.91E-01 3.202 17.061 0.601 1.73E-01 7.83E-01
C20 Rectum 1146 1.006 1.009 1.002 5.87E-04 -0.017 0.007 -0.040 1.58E-01 1.336 3.663 0.487 5.74E-01 6.73E-01
C21 Anus 120 1.003 1.016 0.990 6.82E-01 -0.024 0.028 -0.076 3.61E-01 1.349 18.041 0.101 8.21E-01 4.97E-01
C22 Liver 232 0.992 1.001 0.982 9.26E-02 0.022 0.073 -0.030 4.09E-01 0.804 7.920 0.082 8.52E-01 4.71E-01
C25 Pancreas 498 1.004 1.009 0.998 1.72E-01 -0.019 0.012 -0.050 2.20E-01 0.371 1.307 0.105 1.23E-01 3.16E-01
C32 Larynx 176 1.017 1.022 1.012 9.87E-12 0.044 0.085 0.004 3.31E-02 15.222 140.116 1.654 1.62E-02 3.91E-02
C50 Breast 9131 1.003 1.005 1.001 1.05E-03 0.003 0.017 -0.011 6.51E-01 1.304 1.858 0.914 1.43E-01 1.55E-01
ALL 15584 1.003 1.005 1.002 7.28E-08 0.006 0.017 -0.005 2.62E-01 1.455 1.895 1.455 5.41E-03 2.07E-01
Gastrointestinal 5754 1.002 1.004 1.001 8.65E-03 0.002 0.017 -0.013 7.92E-01 1.365 2.186 1.365 1.96E-01 7.43E-01
L Gastrointestinal 4098 1.004 1.006 1.002 5.97E-06 -0.002 0.015 -0.019 7.81E-01 1.208 2.066 1.208 4.90E-01 6.17E-01
U Gastrointestinal 1831 0.997 1.000 0.994 5.23E-02 0.009 0.033 -0.014 4.33E-01 1.549 3.296 1.549 2.56E-01 8.63E-01
Head & Neck 856 1.010 1.014 1.007 6.01E-10 0.026 0.055 -0.004 8.49E-02 3.862 11.207 3.862 1.29E-02 3.14E-02
I21 Acute MI 4757 0.987 0.989 0.985 8.24E-33 0.007 0.024 -0.009 3.74E-01 1.038 1.730 1.038 8.85E-01 2.98E-01
iCOGS - - - - - - - - - 0.679 1.182 0.774 9.56E-01 8.49E-01
Observational Effect 1-Sample MR (ivprobit) 2-Sample MR
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Figure 1 
Results of 1-Sample MR (ivprobit) analysis for the relationship between alcohol 
consumption in units/week and cancer in light (≤14 units) and heavy (>14 units) drinkers 
and in all participants 
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Supplementary Table 1 
Results of observational analysis for the relationship between alcohol consumption in 
units/week and cancer in light (≤14 units) and heavy (>14 units) drinkers. 
 
Supplementary Table 2 
Results of association analysis for the relationship between rs1229984 and cancer in non-
drinkers, in light (≤14 units) and heavy (>14 units) drinkers, and in all participants. Values 
marked as FAIL indicate that no carriers were present in the cases for a given cancer so the 
results from the analysis cannot be interpreted for that specific cancer. 
 
Supplementary Table 3 
Results of 1-Sample MR (ivprobit) analysis for the relationship between alcohol 
consumption in units/week and cancer in light (≤14 units) and heavy (>14 units) drinkers. 
Values marked as FAIL indicate that no carriers were present in the cases for a given cancer 
so the results from the analysis cannot be interpreted for that specific cancer. 
 
Supplementary Figure 1 
Results of observational analysis for the relationship between alcohol consumption in 
units/week and cancer in light (≤14 units) and heavy (>14 units) drinkers and in all 
participants 
 
Supplementary Figure 2 
Results of 2-Sample MR analysis for the relationship between alcohol consumption in 
units/week and cancer in all participants 
 
 
All rights reserved. No reuse allowed without permission. 
not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprint (which wasthis version posted July 26, 2019. ; https://doi.org/10.1101/19002832doi: medRxiv preprint 
